Parallax Volatility Advisers, L.P. Cara Therapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	BUY	$12.38 - $29.19 $2,562 - $6,042	207 New	207 $3,000
Q2 2019 Aug 14, 2019	SELL	$17.68 - $21.57 $2.15 Million - $2.62 Million	-121,662 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$14.41 - $19.64 $269,524 - $367,346	18,704 Added 18.17%	121,662 $2.39 Million
Q2 2018 Aug 14, 2018	BUY	$11.6 - $19.27 $1.19 Million - $1.98 Million	102,958 New	102,958 $1.97 Million
Q1 2018 May 15, 2018	SELL	$11.77 - $16.08 $47,950 - $65,509	-4,074 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.86 - $14.08 $48,317 - $57,361	4,074	4,074 $50,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.